Detalles de la búsqueda
1.
Extended benefit from sequential administration of docetaxel after standard fluorouracil, epirubicin, and cyclophosphamide regimen for node-positive breast cancer: the 8-year follow-up results of the UNICANCER-PACS01 trial.
Oncologist
; 17(7): 900-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22610153
2.
Topotecan in combination with radiotherapy in unresectable glioblastoma: a phase 2 study.
J Neurooncol
; 93(2): 253-60, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19139825
3.
UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2-positive subgroup.
Eur J Cancer
; 122: 91-100, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31634648
4.
Unexpected toxicities in elderly patients treated with oral idarubicin in metastatic breast cancer: the GINECO experience.
Clin Oncol (R Coll Radiol)
; 16(1): 17-23, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14768751
5.
Trastuzumab for patients with axillary-node-positive breast cancer: results of the FNCLCC-PACS 04 trial.
J Clin Oncol
; 27(36): 6129-34, 2009 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19917839
6.
Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer.
J Clin Oncol
; 26(13): 2099-105, 2008 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18445839
Resultados
1 -
6
de 6
1
Próxima >
>>